Liver-kidney transplantation to cure atypical HUS: Still an option post-eculizumab?

Jeffrey Saland

doi:10.1007/s00467-013-2722-2

Liver-kidney transplantation to cure atypical HUS: Still an option post-eculizumab?

Jeffrey Saland

Research output: Contribution to journal › Review article › peer-review

44 Scopus citations

Abstract

Patients with end-stage renal disease (ESRD) due to atypical HUS (aHUS) now have several potential options that can enable successful kidney transplantation. This editorial addresses these options by considering key factors that are important when making an individual treatment decision.

Original language	English
Pages (from-to)	329-332
Number of pages	4
Journal	Pediatric Nephrology
Volume	29
Issue number	3
DOIs	https://doi.org/10.1007/s00467-013-2722-2
State	Published - Mar 2014

Keywords

Atypical hemolytic uremic syndrome
Eculizumab
Kidney transplantation
Liver transplantation
Resource allocation

Access to Document

10.1007/s00467-013-2722-2

Cite this

@article{86b9b2a401a64ca6838e0ec6ad8f9098,

title = "Liver-kidney transplantation to cure atypical HUS: Still an option post-eculizumab?",

abstract = "Patients with end-stage renal disease (ESRD) due to atypical HUS (aHUS) now have several potential options that can enable successful kidney transplantation. This editorial addresses these options by considering key factors that are important when making an individual treatment decision.",

keywords = "Atypical hemolytic uremic syndrome, Eculizumab, Kidney transplantation, Liver transplantation, Resource allocation",

author = "Jeffrey Saland",

year = "2014",

month = mar,

doi = "10.1007/s00467-013-2722-2",

language = "English",

volume = "29",

pages = "329--332",

journal = "Pediatric Nephrology",

issn = "0931-041X",

publisher = "Springer Verlag",

number = "3",

}

TY - JOUR

T1 - Liver-kidney transplantation to cure atypical HUS

T2 - Still an option post-eculizumab?

AU - Saland, Jeffrey

PY - 2014/3

Y1 - 2014/3

N2 - Patients with end-stage renal disease (ESRD) due to atypical HUS (aHUS) now have several potential options that can enable successful kidney transplantation. This editorial addresses these options by considering key factors that are important when making an individual treatment decision.

AB - Patients with end-stage renal disease (ESRD) due to atypical HUS (aHUS) now have several potential options that can enable successful kidney transplantation. This editorial addresses these options by considering key factors that are important when making an individual treatment decision.

KW - Atypical hemolytic uremic syndrome

KW - Eculizumab

KW - Kidney transplantation

KW - Liver transplantation

KW - Resource allocation

UR - http://www.scopus.com/inward/record.url?scp=84894107600&partnerID=8YFLogxK

U2 - 10.1007/s00467-013-2722-2

DO - 10.1007/s00467-013-2722-2

M3 - Review article

C2 - 24362724

AN - SCOPUS:84894107600

SN - 0931-041X

VL - 29

SP - 329

EP - 332

JO - Pediatric Nephrology

JF - Pediatric Nephrology

IS - 3

ER -

Liver-kidney transplantation to cure atypical HUS: Still an option post-eculizumab?

Abstract

Keywords

Access to Document

Fingerprint

Cite this